Gen-Probe Slaps BD with Second Infringement Suit Related to Molecular Dx Instruments
March 25, 2010
Gen-Probe Slaps BD with Second Infringement Suit Related to Molecular Dx Instruments
The latest suit alleges that the BD Max system infringes upon several patents owned by Gen-Probe and related to its Tigris molecular diagnostics blood-screening system.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Hologic's Gen-Probe Wins Judgment in IP Suit Against BD, but Dispute Remain Unresolved
October 4, 2012 / PCR Insider - Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test
April 11, 2013 / PCR Insider - BD, Gen-Probe Settle Patent Dispute
December 4, 2012 / GenomeWeb Daily News - Court Rules in Favor of Hologic's Gen-Probe in Patent Infringement Suit with BD
October 4, 2012 / GenomeWeb Daily News - Exiqon Licenses LNA Tech to BD for Use in PCR-Based Infectious Disease Dxs
June 24, 2010 / PCR Insider